FI955587A - Chemical compounds - Google Patents
Chemical compounds Download PDFInfo
- Publication number
- FI955587A FI955587A FI955587A FI955587A FI955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A
- Authority
- FI
- Finland
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
| PCT/EP1994/001613 WO1994027989A1 (en) | 1993-05-21 | 1994-05-19 | Carbazole derivatives with 17,20-lyase-inhibiting activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI955587A true FI955587A (en) | 1995-11-20 |
| FI955587A0 FI955587A0 (en) | 1995-11-20 |
Family
ID=10736007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI955587A FI955587A0 (en) | 1993-05-21 | 1995-11-20 | Chemical compounds |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0699196A1 (en) |
| JP (1) | JPH08510455A (en) |
| CN (1) | CN1126473A (en) |
| AU (1) | AU6928794A (en) |
| BG (1) | BG100154A (en) |
| CA (1) | CA2162921A1 (en) |
| CZ (1) | CZ305195A3 (en) |
| FI (1) | FI955587A0 (en) |
| GB (1) | GB9310635D0 (en) |
| HU (1) | HUT73790A (en) |
| IL (1) | IL109703A0 (en) |
| NO (1) | NO954681L (en) |
| OA (1) | OA10195A (en) |
| PE (1) | PE31195A1 (en) |
| PL (1) | PL311702A1 (en) |
| SK (1) | SK142495A3 (en) |
| TW (1) | TW279866B (en) |
| WO (1) | WO1994027989A1 (en) |
| ZA (1) | ZA943494B (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR960704852A (en) * | 1993-09-30 | 1996-10-09 | 오노다 마사요시 | Azole derivatives and pharmaceutical compositions thereof |
| WO1996014090A1 (en) * | 1994-11-07 | 1996-05-17 | Janssen Pharmaceutica N.V. | Compositions comprising carbazoles and cyclodextrins |
| AU702406B2 (en) * | 1995-03-01 | 1999-02-18 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazole derivatives and medicinal composition thereof |
| ATE231128T1 (en) * | 1997-02-21 | 2003-02-15 | Takeda Chemical Industries Ltd | JOINTS WITH CONDENSED RINGS, METHOD FOR THEIR PRODUCTION AND THEIR APPLICATION |
| CN100572363C (en) | 2000-11-17 | 2009-12-23 | 武田药品工业株式会社 | Imdazole derivatives, Its Preparation Method And Use |
| US6960586B2 (en) | 2000-11-20 | 2005-11-01 | Takeda Pharmaceutical Company Limited | Imidazole derivatives, process for their preparation and their use |
| CA2431171A1 (en) | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| MX2007015905A (en) * | 2005-06-24 | 2008-03-06 | Lilly Co Eli | Tetrahydrocarbazole derivatives useful as androgen receptor modulators. |
| GB0525323D0 (en) | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
| US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
| CN100586932C (en) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | Antitumor compound and its preparation process |
| GEP20156250B (en) | 2009-06-26 | 2015-02-25 | Novartis Ag | 1,3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17 |
| CA2788907A1 (en) * | 2010-02-04 | 2011-08-11 | Radius Health, Inc. | Selective androgen receptor modulators |
| MX342898B (en) | 2010-05-12 | 2016-10-18 | Radius Health Inc * | Therapeutic regimens. |
| JP5998137B2 (en) | 2010-08-04 | 2016-09-28 | ペルフィキュア ファーマシューティカルズ，インコーポレイテッド | Combination therapy to treat prostate cancer |
| EP2627648A1 (en) | 2010-09-16 | 2013-08-21 | Novartis AG | 17aHYDROXYLASE/C17,20-LYASE INHIBITORS |
| ES2550319T3 (en) | 2010-09-28 | 2015-11-06 | Radius Health, Inc | Selective androgen receptor modulators |
| ES2656218T3 (en) | 2011-04-28 | 2018-02-26 | Novartis Ag | 17 alpha-hydroxylase / C17,20-lyase inhibitors |
| US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| WO2014158875A1 (en) | 2013-03-14 | 2014-10-02 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
| SI3122426T1 (en) | 2014-03-28 | 2023-04-28 | Duke University | Treating breast cancer using selective estrogen receptor modulators |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| US10093620B2 (en) | 2014-09-12 | 2018-10-09 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| LT3474841T (en) | 2016-06-22 | 2022-06-10 | Ellipses Pharma Ltd | Ar+ breast cancer treatment methods |
| EP3528799A1 (en) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
| LT3565542T (en) | 2017-01-05 | 2024-07-10 | Radius Pharmaceuticals, Inc. | Polymorphic forms of rad1901-2hcl |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/en unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 PL PL94311702A patent/PL311702A1/en unknown
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 CA CA002162921A patent/CA2162921A1/en not_active Abandoned
- 1994-05-19 SK SK1424-95A patent/SK142495A3/en unknown
- 1994-05-19 CN CN94192683A patent/CN1126473A/en active Pending
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/en not_active Application Discontinuation
- 1994-05-19 EP EP94917647A patent/EP0699196A1/en not_active Withdrawn
- 1994-05-19 JP JP7500181A patent/JPH08510455A/en active Pending
- 1994-05-19 HU HU9503321A patent/HUT73790A/en unknown
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/en unknown
- 1994-05-20 IL IL10970394A patent/IL109703A0/en unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/en not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 NO NO954681A patent/NO954681L/en unknown
- 1995-11-20 FI FI955587A patent/FI955587A0/en not_active Application Discontinuation
- 1995-11-21 BG BG100154A patent/BG100154A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2162921A1 (en) | 1994-12-08 |
| ZA943494B (en) | 1995-01-23 |
| BG100154A (en) | 1996-07-31 |
| EP0699196A1 (en) | 1996-03-06 |
| GB9310635D0 (en) | 1993-07-07 |
| SK142495A3 (en) | 1996-06-05 |
| TW279866B (en) | 1996-07-01 |
| FI955587A0 (en) | 1995-11-20 |
| IL109703A0 (en) | 1994-08-26 |
| JPH08510455A (en) | 1996-11-05 |
| OA10195A (en) | 1996-12-18 |
| AU6928794A (en) | 1994-12-20 |
| PL311702A1 (en) | 1996-03-04 |
| NO954681D0 (en) | 1995-11-20 |
| NO954681L (en) | 1995-11-20 |
| CN1126473A (en) | 1996-07-10 |
| PE31195A1 (en) | 1995-10-18 |
| HUT73790A (en) | 1996-09-30 |
| WO1994027989A1 (en) | 1994-12-08 |
| HU9503321D0 (en) | 1996-01-29 |
| CZ305195A3 (en) | 1996-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG96392A (en) | CHEMICAL COMPOUNDS | |
| FI955587A (en) | Chemical compounds | |
| MX9101375A (en) | CHEMICAL COMPOUNDS | |
| BR1101108A (en) | Compound | |
| ID15985A (en) | CHEMICAL COMPOUND | |
| DK72693D0 (en) | COMPOUNDS | |
| MX9202262A (en) | CHEMICAL COMPOUNDS. | |
| NO951433D0 (en) | Chemical connections | |
| FI945907A (en) | Chemical compounds | |
| FI932571A (en) | CHEMICAL PROCESS | |
| DK124393D0 (en) | COMPOUNDS | |
| FI944825A0 (en) | Phenylbenzoamide - based fungicidal compounds | |
| DE59409946D1 (en) | Anti-droning compounds. | |
| FI961520A (en) | Heribicidal azabisphosphonic acid compounds | |
| KR970707090A (en) | 18-Nor-Vitamin D Compounds | |
| NO962264D0 (en) | Chemical connections | |
| MX9205851A (en) | CHEMICAL COMPOUNDS | |
| FI954399A0 (en) | Chemical process | |
| DK244090D0 (en) | CHEMICAL COMPOUNDS | |
| ITRM940566A0 (en) | ORGANIC COMPOUNDS | |
| DK150591D0 (en) | CHEMICAL COMPOUND | |
| DK85393D0 (en) | CHEMICAL COMPOUND | |
| DK39992D0 (en) | CHEMICAL COMPOUNDS | |
| DK102693D0 (en) | NOVEL COMPOUNDS | |
| KR950013225U (en) | Distiller |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |